Truist lowered the firm’s price target on Caesars (CZR) to $30 from $32 and keeps a Buy rating on the shares after its Q3 EBITDA miss. Las Vegas summer weakness and low hold impacted results, but an expected group recovery for Q4 remains on pace with leisure trends seen as the main unknown, the analyst tells investors in a research note. Caesars has been a challenging stock to own, but the firm sees risk reward skewed positive at this valuation, Truist added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CZR:
- Nevada reports September statewide gaming win down 2.3% to $1.28B
- Caesars price target lowered to $37 from $43 at Stifel
- Caesars price target lowered to $38 from $43 at JPMorgan
- Caesars price target lowered to $25 from $29 at Goldman Sachs
- Positive Outlook for Caesars Entertainment Despite Q3 Shortfall: Buy Rating Affirmed by Lance Vitanza